Lippoldt Darin 4
4 · NEUROCRINE BIOSCIENCES INC · Filed Jan 12, 2026
Insider Transaction Report
Form 4
Lippoldt Darin
Chief Legal Officer
Transactions
- Exercise/Conversion
Common Stock
2026-01-08$35.99/sh+3,349$120,531→ 46,754 total - Exercise/Conversion
Incentive Stock Option
[F1]2026-01-08−3,349→ 0 totalExercise: $35.99Exp: 2026-02-05→ Common Stock (3,349 underlying)
Footnotes (1)
- [F1]The option was granted February 5, 2016 and vested monthly over four years. These options were due to expire on February 5, 2026.
Signature
/s/ Darin Lippoldt|2026-01-12